Sustained Release of Antivirals for Treatment and Prevention of HIV (SRATP) (R01)

Funding Opportunity Announcement (FOA) Number	PAR -13-349
Companion Funding Opportunity	None
Number of Applications	See Section III. 3. Additional Information on Eligibility.
Catalog of Federal Domestic Assistance (CFDA) Number(s)	93.856; 93.855; 93.865; 93.242
Funding Opportunity Purpose	The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications that address the long term goal and objective of developing sustained release strategies for HIV treatment or prevention. Applications may propose treatment or prevention products delivered using sustained release platforms (oral, injection, implant or direct delivery to HIV target mucosa) that will provide a minimum of one week (treatment) or one month (prevention) of efficacy/protection.

Key Dates

Posted Date	September 11, 2013
Open Date (Earliest Submission Date)	December 7, 2013
Letter of Intent Due Date(s)	Not Applicable.
Application Due Date(s)	January 7, 2014; January 7, 2015; January 7, 2016, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)	January 7, 2014; January 7, 2015; January 7, 2016